Photochemotherapy for psoriasis with orally administered methoxsalen. 1976

K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum

Photochemotherapy denotes a therapeutic approach that is based on the interaction of light and a photoactive drug. This study describes the efficacy of photochemotherapy, using orally administered methoxsalen and long-wave ultraviolet light in 91 patients with severe, generalized psoriasis. Oral administration of methoxsalen was followed by exposure to a high-intensity long-wave ultraviolet light source, emitting a continuous spectrum between 320 and 390 nm (peak, 365 nm) and an energy of 5.6 to 7.5 mw/sq cm at 15 cm. There was complete clearing of 82 patients (90%), a 90% to 100% clearing in seven (8%), and a satisfactory improvement in two (2%). A paired comparison study in 54 patients showed photochemotherapy to be far more effective than ultraviolet light emitted by fluorescent bulbs or a xenon source. Eighty-five percent of the patients receiving outpatient maintenance treatment have remained in remission for periods up to 400 days.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010858 Pigmentation Coloration or discoloration of a part by a pigment. Pigmentations
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response

Related Publications

K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
November 1979, Archives of dermatology,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
September 1980, International journal of dermatology,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
July 1981, American journal of hospital pharmacy,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
December 1974, The New England journal of medicine,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
March 1979, The British journal of dermatology,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
April 1979, The New England journal of medicine,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
April 1979, Cancer treatment reports,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
January 1976, Przeglad dermatologiczny,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
November 1977, Archives of dermatology,
K W Wolff, and T B Fitzpatrick, and J A Parrish, and F Gschnait, and B Gilchrest, and H Hönigsmann, and M A Pathak, and L Tannenbaum
June 1977, The Journal of investigative dermatology,
Copied contents to your clipboard!